Artivion, Inc. (AORT)
- Sector
- Healthcare
- Industry
- Medical Devices
- Last price
- $18.27
- As of
Kresmion compiles this page from AORT's SEC filings, its 13F institutional holders and the market events Kresmion detects, each linked to its source.
ARTIVION, INC. (AORT): 6 institutional managers tracked by Kresmion reported non-option positions in their 2026Q3 Form 13F filings, and the most recent SEC filing on record for the company is a Form 10-Q filed 2026-11-06.
See the full AORT dossier
Price with insider and filing markers, who is positioning, fundamentals and peers for AORT on one page. Preview it with sample data, then open it live with a free account.
Preview the AORT dossierActive events for AORT
- medium13F: new position
Point72 Asset Management, L.P. new position in AORT
- high13F: large increase
MILLENNIUM MANAGEMENT LLC added +509% to AORT (2026Q3)
- high13F: large reduction
TWO SIGMA INVESTMENTS, LP cut 84% of AORT (2026Q3)
- high13F: large reduction
RENAISSANCE TECHNOLOGIES LLC cut 84% of AORT (2026Q3)
- mediumEarnings below estimates
Q3-2026: Missed consensus by 156.0%, EPS $-0.16 vs $-0.0625 estimate
FREE, NO ACCOUNT
Every event on AORT, as it fires
You are seeing 5 of 11 events recorded on AORT since 2026-07-24.
The five above landed across 3 days. The other 6 were recorded on 4 other days. 8 of the 11 are institutional flow rows, which arrive in batches on filing days.
No fixed schedule: it goes out when the data has something in it. Unsubscribe anytime. We never sell your data.
AORT positions held by the managers we follow (2026Q3)
What the managers we follow bought and sold in Q3 2026
| Manager / security | Market value | % of reported value |
|---|---|---|
| CITADEL ADVISORS LLC FundCUSIP 228903100 · 2026Q3 | $26.1M | 0.01% |
| MILLENNIUM MANAGEMENT LLC FundCUSIP 228903100 · 2026Q3 | $12.8M | 0.01% |
| D. E. Shaw & Co., Inc. FundCUSIP 228903100 · 2026Q3 | $11.3M | 0.01% |
| TWO SIGMA INVESTMENTS, LP FundCUSIP 228903100 · 2026Q3 | $1.4M | 0.00% |
| Point72 Asset Management, L.P. FundCUSIP 228903100 · 2026Q3 | $948K | 0.00% |
| RENAISSANCE TECHNOLOGIES LLC FundCUSIP 228903100 · 2026Q3 | $249K | 0.00% |
Quarterly SEC Form 13F disclosures from the managers Kresmion tracks, not a complete ownership ranking. Non-option holdings only; reported put and call positions are excluded. Different securities are labeled by CUSIP. The share of reported value is each position's value over the sum of the values that manager reported for the quarter; option lines are not in that sum, as on each fund page. Values are reporting-period snapshots, not current position values. Filings can arrive up to 45 days after quarter-end.
Recent SEC filings, AORT
- 10-QSEC EDGAR ↗
- 8-KSEC EDGAR ↗
- 10-QSEC EDGAR ↗
- 8-KSEC EDGAR ↗
- 8-KSEC EDGAR ↗
- 8-KSEC EDGAR ↗
- 10-QSEC EDGAR ↗
- 8-KSEC EDGAR ↗
- 10-KSEC EDGAR ↗
- 8-KSEC EDGAR ↗
More data on AORT
- AORT share buybacks Cash paid for repurchases, shares bought and program authorizations, from SEC filings.
- AORT insider trading clusters Three or more insiders filing the same direction within 30 days, from SEC Form 4.
- AORT against its peers Growth, margins and valuation beside the industry median, from annual SEC filings.
AORT against its peers
AORT's operating margin of 7.6% ranks in the 78th percentile of 19 Medical Devices sub-industry peers, fiscal periods ending between 2025-12-28 and 2025-12-31.
| Metric | AORT | Peer median | Percentile | n |
|---|---|---|---|---|
| Revenue FY | 441M USD | 213M USD | 73 | 19 |
| Gross margin | 64.4% | 64.6% | 50 | 18 |
| Operating margin | 7.6% | -25.5% | 78 | 19 |
| Net margin | 2.2% | -24.2% | 68 | 19 |
| Return on equity | 2.2% | -18.4% | 66 | 18 |
| P / E | 87.0x | 31.8x | 75 | 5 |
| 1 year | -59.1% | 43.3% | 3 | 18 |
Peers (19): BBNX, KIDS, CBLL, SIBN, INMD, QDEL, IART, DCTH, AVNS.D, TCMD, SENS, BFLY, ENOV, RCEL, MASS, ESTA, VMD, TMCI, UFPT. Left out: LMRI (no annual filing), NHNKF (no annual filing), OSSUY (no annual filing), MOBI (no annual filing), BWAY (period gap), ALMR (no annual filing). Fiscal periods ending between 2025-12-28 and 2025-12-31. Every figure is one full fiscal year read from one annual filing (AORT: 10-K), reported in USD. Nothing is trailing twelve months and nothing is converted between currencies. Source: SEC EDGAR XBRL company facts (public domain); prices from Kresmion's daily equity market-data snapshot. Open the full comparison.
Related tickers
Cite this data
Kresmion counts the managers it follows that reported a non-option position in AORT on Form 13F-HR for the latest reporting quarter, orders those positions by the value each filing reports, and lists the company's latest SEC filings and the events Kresmion recorded on AORT in the last 180 days.
Upstream: SEC EDGAR filings for AORT
Kresmion, "ARTIVION, INC. (AORT) institutional holdings and SEC filings", data as of 2026-11-18, https://kresmion.com/research/AORT. Upstream data: SEC EDGAR filings for AORT.
Link to this data (HTML):
<a href="https://kresmion.com/research/AORT">ARTIVION, INC. (AORT) institutional holdings and SEC filings (Kresmion)</a>
Writing about this? Press contact and ready-to-quote figures
Follow AORT on a live board
Kresmion is a source-first market terminal for cross-asset market intelligence. Open a board scoped to AORT for its filings, 13F changes, insider trades, options positioning, and confluence read in one view, each with its source.